Business Model

One of the Company’s key goals is to obtain FDA certification and renew its current CE certificate in Europe in accordance with the new Medical Device Regulations (MDR). After obtaining certification, Mofema plans to acquire strategic industry partners who already have a developed distribution network. These can be networks of medical facilities or telemedicine platforms. The Company does not intend to run and develop its own distribution network. Another possible commercialization model is the sale of a license for the PregnaLIFE24 system or all of the rights to this project. Potential partners could be companies that already sell the CTG devices, which may want to add the eCTG telemedicine based system to their portfolio. Telemedicine platforms cooperate with many medical entities on the market. In partnership with a telemedicine platform, the Company could reach the global market generating potentially higher sales volume. The company could provide data processing service to telemedicine platforms. This cooperation would allow the company to keep the service unit cost at a relatively lower level, and potentially achieve higher margin due to the automation of the service.